Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Bank of New York Mellon Corp (BK), Mondelez International Inc (MDLZ): Billionaire Nelson Peltz Keeps Buying More Shares

Page 1 of 2

Nelson Peltz‘s Trian Partners has recently reported increasing its activist stakes in two companies: Bank of New York Mellon Corp (NYSE:BK) and Mondelez International Inc (NASDAQ:MDLZ). In a new Form 4 filing, Trian disclosed the acquisition of 784,800 shares of Bank of New York Mellon at an average weighted price of $39.78 per unit; following the increase, the stake amasses close to 29.96 million shares of the company. In Mondelez, the fund bought 270,900 shares at $36.94 per share, which raised the stake to 47.48 million shares. In both companies, Trian has representatives on the board of directors, with Mr. Peltz serving on Mondelez’s board and Edward Garden acting as a board director at Bank of New York Mellon.


Mr. Peltz holds a relatively concentrated portfolio that contain stakes in 11 companies with a total value of $9.43 billion. The top five picks amass over 75% of the total portfolio value and the fund has its representatives on the board of directors in three of those five companies: Mondelez International Inc (NASDAQ:MDLZ), Bank of New York Mellon Corp (NYSE:BK), and Ingersoll-Rand PLC (NYSE:IR), while in the other two companies, E. I. du Pont de Nemours and Company (NYSE: DD) and PepsiCo, Inc. (NYSE:PEP), the investor holds activist positions. Moreover, in January Trian and PepsiCo reached an agreement under the terms of which the company will appoint William R. Johnson, the former CEO of H.J. Heinz and an adviser of Trian, as an independent director. The move comes after a two-year long battle during which Mr. Peltz has been mainly arguing that PepsiCo should spin-off its beverages segment from its snacks segment, the latter being considered more profitable. On the other hand, Mr. Peltz’s fight with DuPont is only just beginning, as the investor has recently announced his intention to appoint four directors to the board, including himself.

In Bank of New York Mellon, Trian initiated a 2.3% stake during the second quarter of 2014, sparking a lot of talks regarding a potential spin-off of the bank’s management business. However, instead, the investor has been pushing for cost cutting and other measures. Mr. Peltz’s move into Bank of New York is unusual, since big activists like Carl Icahn prefer to keep their distance from financial companies, especially since the financial crisis in 2008. In December, Trian and Bank of New York Mellon Corp (NYSE:BK)  struck a deal to appoint the fund’s co-founder (and Peltz’s son-in-law) Edward Garden as the 14th director to the board.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!